Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Dual-Chamber Pacers Help Reduce Thromboembolic Event Risk - AHA Study

This article was originally published in The Gray Sheet

Executive Summary

Use of dual-chamber in lieu of single-chamber pacemakers for ventricular pacing can lower platelet activation in the heart and reduce the risk of thromboembolic events, William Toff, MD, University of Leicester (UK) told attendees of the American Heart Association's scientific sessions Nov. 10 in Atlanta.

You may also be interested in...

Dual-Chamber v. Single-Chamber Pacemaker Use Debated At NASPE

Anticipated results from two early stage studies - the Mode Selection Trial (MOST) and the PAGE trial in the UK - will further support evidence to date that use of dual-chamber pacemakers is unnecessary in the majority of patients, according to Ronald Vliestra, MD, Watson Clinic, Lakeland, Florida.

Finance Watch: Silverback, Kinnate, Sigilon Launch December’s First IPOs

Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts